title: Fowl adenovirus: history, emergence, biology and development of a vaccine against hydropericardium syndrome.
abstract: The poultry industry has emerged as one of the largest and fastest growing public sectors in the developed and developing countries. Unfortunately, this industry is under a major threat from diseases that are viral (Newcastle disease, infectious bursal disease, influenza, hydropericardium syndrome), bacterial (colibacillosis, pasteurellosis, salmonellosis, mycoplasmosis), parasitic (coccidiosis, histoplasmosis) or nutritional (dyschondroplasia, osteoporosis). Among these diseases, hydropericardium syndrome (HPS) is one of the important emerging diseases occurring in the specific areas of the world where broilers (chickens) are reared under intensive conditions. HPS was first observed in 1987 at Angara Goth, an area near Karachi, Pakistan, where broilers are raised. Since then, HPS has been reported in many countries of the world. From these reported cases, an adenovirus that was either isolated from or visualized electron microscopically in the liver of affected broilers has been implicated in the syndrome. The syndrome has been reproduced by inoculation of isolated fowl adenovirus (FAdV) strains, and hence, the syndrome is also called infectious hydropericardium syndrome. To our knowledge, HPS has not been observed in humans, so it is not considered a zoonotic disease, but it is of economic importance and causes huge losses to the poultry industry. Efforts have been made to develop conventional vaccines against this disease, which were formulated from infected liver homogenate. Formalin-inactivated liver organ vaccines have failed to protect the poultry industry. Hence, there is a dire need to develop a suitable vaccine to combat this disease. Currently, recombinant vaccine candidates are being developed by using molecular biology and biotechnological approaches for the prevention and control of infectious diseases, including HPS. Therefore, it is suggested that the immunogenicity of these recombinant proteins should be evaluated for their use as subunit vaccines.
authors.affiliation: Department of Pathobiology and Veterinary Sciences, University of Connecticut, Storrs, USA. msalahuddin786@hotmail.com.|National Institute of Biotechnology and Genetic Engineering (NIBGE), Faisalabad, Pakistan. msalahuddin786@hotmail.com.
authors.forename: M S
authors.initials: MS
authors.lastname: Shah
authors.affiliation: Department of Zoology, G.C University, Faisalabad, Pakistan.
authors.forename: A
authors.initials: A
authors.lastname: Ashraf
authors.affiliation: Department of Pathobiology and Veterinary Sciences, University of Connecticut, Storrs, USA.
authors.forename: M I
authors.initials: MI
authors.lastname: Khan
authors.affiliation: National Institute of Biotechnology and Genetic Engineering (NIBGE), Faisalabad, Pakistan.
authors.forename: M
authors.initials: M
authors.lastname: Rahman
authors.affiliation: Nuclear Institute for Agriculture and Biology (NIAB), Faisalabad, Pakistan.
authors.forename: M
authors.initials: M
authors.lastname: Habib
authors.affiliation: Nuclear Institute for Agriculture and Biology (NIAB), Faisalabad, Pakistan.
authors.forename: M I
authors.initials: MI
authors.lastname: Chughtai
authors.affiliation: National Institute of Biotechnology and Genetic Engineering (NIBGE), Faisalabad, Pakistan.|University of Lahore, Defense Road, Lahore, Pakistan.
authors.forename: J A
authors.initials: JA
authors.lastname: Qureshi
mesh_terms: D000257:Adenoviridae Infections / Q000517:prevention & control / Q000662:veterinary* / Q000821:virology; D000818:Animals; D025681:Fowl adenovirus A / Q000502:physiology*; D011200:Poultry; D011201:Poultry Diseases / Q000517:prevention & control* / Q000821:virology; D014765:Viral Vaccines / Q000276:immunology*
chemical_list: D014765:Viral Vaccines